The molecular mechanisms underlying BCR/ABL degradation in chronic myeloid leukemia cells promoted by Beclin1-mediated autophagy

References

• Mughal TI, Radich JP, Deininger MW, et al. Chronic myeloid leukemia: reminiscences and dreams. Haematologica. 2016;101(5):541–558. doi:10.3324/haematol.2015.13933727132280
   PubMed Web of Science ®Google Scholar
• Wei G, Rafiyath S, Liu D. First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib. J Hematol Oncol. 2010;3:47. doi:10.1186/1756-8722-3-5021108851
   PubMed Web of Science ®Google Scholar
• Yang K, Fu LW. Mechanisms of resistance to BCR-ABL TKIs and the therapeutic strategies: a review. Crit Rev Oncol Hematol. 2015;93(3):277–292. doi:10.1016/j.critrevonc.2014.11.00125500000
   PubMed Web of Science ®Google Scholar
• Soverini S, Rosti G, Iacobucci I, Baccarani M, Martinelli G. Choosing the best second-line tyrosine kinase inhibitor in imatinib-resistant chronic myeloid leukemia patients harboring Bcr-Abl kinase domain mutations: how reliable is the IC50? Oncologist. 2011;16(6):868–876. doi:10.1634/theoncologist.2010-038821632458
   PubMed Web of Science ®Google Scholar
• Chomel JC, Bonnet ML, Sorel N, et al. Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease. Blood. 2011;118(13):3657–3660. doi:10.1182/blood-2011-02-33549721791426
   PubMed Web of Science ®Google Scholar
• Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132(1):27–42. doi:10.1016/j.cell.2007.12.01818191218
   PubMed Web of Science ®Google Scholar
• Kumar A, Singh UK, Chaudhary A. Targeting autophagy to overcome drug resistance in cancer therapy. Future Med Chem. 2015;7(12):1535–1542. doi:10.4155/fmc.15.8826334206
   PubMed Web of Science ®Google Scholar
• Lin YX, Wang Y, An HW, et al. Peptide-based autophagic gene and cisplatin co-delivery systems enable improved chemotherapy resistance. Nano Lett. 2019;19:2968–2978. [Epub ahead of print]. doi:10.1021/acs.nanolett.9b0008330924343
   PubMed Web of Science ®Google Scholar
• Bellodi C, Lidonnici MR, Hamilton A, et al. Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J Clin Invest. 2009;119(5):1109–1123. doi:10.1172/JCI3566019363292
   PubMed Web of Science ®Google Scholar
• Crowley LC, Elzinga BM, O’Sullivan GC, McKenna SL. Autophagy induction by Bcr-Abl-expressing cells facilitates their recovery from a targeted or nontargeted treatment. Am J Hematol. 2011;86(1):38–47. doi:10.1002/ajh.2191421132731
   PubMed Web of Science ®Google Scholar
• Qu X, Yu J, Bhagat G, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest. 2003;112(12):1809–1820. doi:10.1172/JCI2003914638851
   PubMed Web of Science ®Google Scholar
• Liang C, Feng P, Ku B, et al. Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat Cell Biol. 2006;8(7):688–699. doi:10.1038/ncb142616799551
   PubMed Web of Science ®Google Scholar
• Watson AS, Mortensen M, Simon AK. Autophagy in the pathogenesis of myelodysplastic syndrome and acute myeloid leukemia. Cell Cycle. 2011;10(11):1719–1725. doi:10.4161/cc.10.11.1567321512311
   PubMed Web of Science ®Google Scholar
• Ramsingh G, Jacoby MA, Shao J, et al. Acquired copy number alterations of miRNA genes in acute myeloid leukemia are uncommon. Blood. 2013;122(15):44–51. doi:10.1182/blood-2013-03-48800723678004
   PubMed Web of Science ®Google Scholar
• Zare-Abdollahi D, Safari S, Movafagh A, et al. Expression analysis of BECN1 in acute myeloid leukemia: association with distinct cytogenetic and molecular abnormalities. Int J Lab Hematol. 2016;38(2):125–132. doi:10.1111/ijlh.1245426765290
   PubMed Web of Science ®Google Scholar
• Laane E, Tamm KP, Buentke E, et al. Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy. Cell Death Differ. 2009;16(7):1018–1029. doi:10.1038/cdd.2009.4619390558
   PubMed Web of Science ®Google Scholar
• Bonapace L, Bornhauser BC, Schmitz M, et al. Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance. J Clin Invest. 2010;120(4):1310–1323. doi:10.1172/JCI3998720200450
   PubMed Web of Science ®Google Scholar
• Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 2011;18(4):571–580. doi:10.1038/cdd.2010.19121311563
   PubMed Web of Science ®Google Scholar
• Liang PQ, Miao M, Liu ZG, et al. Expression of autophagy genes in acute myeloid leukemia: associations with clinical characteristics and prognosis. Neoplasma. 2018;65(5):807–814. doi:10.4149/neo_2018_171028N69129940753
   PubMed Web of Science ®Google Scholar
• Radwan SM, Hamdy NM, Hegab HM, El-Mesallamy HO. Beclin-1 and hypoxia-inducible factor-1α genes expression: potential biomarkers in acute leukemia patients. Cancer Biomark. 2016;16(4):619–626. doi:10.3233/CBM-16060327002764
   PubMed Web of Science ®Google Scholar
• Cicchini M, Chakrabarti R, Kongara S, et al. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. Autophagy. 2014;10(11):2036–2052. doi:10.4161/auto.3439825483966
   PubMed Web of Science ®Google Scholar
• Elgendy M, Sheridan C, Brumatti G, Martin SJ. Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival. Mol Cell. 2011;42(1):23–35. doi:10.1016/j.molcel.2011.02.00921353614
   PubMed Web of Science ®Google Scholar
• Tong Y, You L, Liu H, et al. Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia. Oncotarget. 2013;4(6):860–874. doi:10.18632/oncotarget.101823765161
   PubMedGoogle Scholar
• Graham SM, Jørgensen HG, Allan E, et al. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood. 2002;99(1):319–325.11756187
   PubMed Web of Science ®Google Scholar
• Jin Y, Lu Z, Ding K, et al. Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species. Cancer Res. 2010;70(6):2516–2527. doi:10.1158/0008-5472.CAN-09-395020215516
   PubMed Web of Science ®Google Scholar
• Marega M, Piazza RG, Pirola A, et al. BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients. Leukemia. 2010;24(8):1445–1449. doi:10.1038/leu.2010.10120520635
   PubMed Web of Science ®Google Scholar
• Shi X, Chen X, Li X, et al. Gambogic acid induces apoptosis in imatinib-resistant chronic myeloid leukemia cells via inducing proteasome inhibition and caspase-dependent Bcr-Abl downregulation. Clin Cancer Res. 2014;20(1):151–163. doi:10.1158/1078-0432.CCR-13-106324334603
   PubMed Web of Science ®Google Scholar
• Tang B, Cai J, Sun L, et al. Proteasome inhibitors activate autophagy involving inhibition of PI3K-Akt-mTOR pathway as an anti-oxidation defense in human RPE cells. PLoS One. 2014;9(7):e103364. doi:10.1371/journal.pone.010336425062253
   PubMed Web of Science ®Google Scholar
• Sha Z, Schnell HM, Ruoff K, Goldberg A. Rapid induction of p62 and GABARAPL1 upon proteasome inhibition promotes survival before autophagy activation. J Cell Biol. 2018;217(5):1757–1776. doi:10.1083/jcb.20170816829535191
   PubMed Web of Science ®Google Scholar
• Morselli E, Galluzzi L, Kepp O, et al. Anti- and pro-tumor functions of autophagy. Biochim Biophys Acta. 2009;1793(9):1524–1532. doi:10.1016/j.bbamcr.2009.01.00619371598
   PubMed Web of Science ®Google Scholar
• Jin S, Wei J, You L, Liu H, Qian W. Autophagy regulation and its dual role in blood cancers: a novel target for therapeutic development. Oncol Rep. 2018;39(6):2473–2481. doi:10.3892/or.2018.637029658589
   PubMed Web of Science ®Google Scholar
• Goussetis DJ, Gounaris E, Wu EJ, et al. Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxide. Blood. 2012;120(17):3555–3562. doi:10.1182/blood-2012-01-40257822898604
   PubMed Web of Science ®Google Scholar
• Shi X, Jin Y, Cheng C, et al. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation. Clin Cancer Res. 2009;15(5):1686–1697. doi:10.1158/1078-0432.CCR-08-214119240172
   PubMed Web of Science ®Google Scholar
• Nimmanapalli R, Bali P, O’Bryan E, et al. Arsenic trioxide inhibits translation of mRNA of bcr-abl, resulting in attenuation of Bcr-Abl levels and apoptosis of human leukemia cells. Cancer Res. 2003;63(22):7950–7958.14633726
   PubMed Web of Science ®Google Scholar
• Mao JH, Sun XY, Liu JX, et al. As4S4 targets RING-type E3 ligase c-CBL to induce degradation of BCR-ABL in chronic myelogenous leukemia. Proc Natl Acad Sci U S A. 2010;107(50):21683–21688. doi:10.1073/pnas.101631110821118980
   PubMed Web of Science ®Google Scholar
• Elzinga BM, Nyhan MJ, Crowley LC, O’Donovan TR, Cahill MR, McKenna SL. Induction of autophagy by Imatinib sequesters Bcr-Abl in autophagosomes and down-regulates Bcr-Abl protein. Am J Hematol. 2013;88(6):455–462. doi:10.1002/ajh.2342823440701
   PubMed Web of Science ®Google Scholar
• Chen HY, White E. Role of autophagy in cancer prevention. Cancer Prev Res (Phila). 2011;4(7):973–983. doi:10.1158/1940-6207.CAPR-10-038721733821
   PubMed Web of Science ®Google Scholar
• Degenhardt K, Mathew R, Beaudoin B, et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell. 2006;10(1):51–64. doi:10.1016/j.ccr.2006.06.00116843265
   PubMed Web of Science ®Google Scholar
• Strohecker AM, White E. Autophagy promotes BrafV600E-driven lung tumorigenesis by preserving mitochondrial metabolism. Autophagy. 2014;10(2):384–385. doi:10.4161/auto.2732024362353
   PubMed Web of Science ®Google Scholar
• Thorburn A, Thamm DH, Gustafson DL. Autophagy and cancer therapy. Mol Pharmacol. 2014;85(6):830–838. doi:10.1124/mol.114.09185024574520
   PubMed Web of Science ®Google Scholar
• Wu S, He Y, Qiu X, et al. Targeting the potent Beclin 1-UVRAG coiled-coil interaction with designed peptides enhances autophagy and endolysosomal trafficking. Proc Natl Acad Sci U S A. 2018;115(25):E5669–E5678. doi:10.1073/pnas.172117311529866835
   PubMed Web of Science ®Google Scholar
• Yu L, Alva A, Su H, et al. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science. 2004;304(5676):1500–1502. doi:10.1126/science.109664515131264
   PubMed Web of Science ®Google Scholar
• Karvela M, Baquero P, Kuntz EM, et al. ATG7 regulates energy metabolism, differentiation and survival of Philadelphia-chromosome-positive cells. Autophagy. 2016;12(6):936–948. doi:10.1080/15548627.2016.116235927168493
   PubMed Web of Science ®Google Scholar
• Bjørkøy G, Lamark T, Pankiv S, Øvervatn A, Brech A, Johansen T. Monitoring autophagic degradation of p62/SQSTM1. Methods Enzymol. 2009;452:181–197. doi:10.1016/S0076-6879(08)03612-419200883
   PubMed Web of Science ®Google Scholar